Literature DB >> 12641996

Glutamine Analogues As Adjunctive Therapy for Infectious Diarrhea.

Benedito A. Carneiro-Filho1, Oluma Y. Bushen, Gerly A.C. Brito, Aldo A.M. Lima, Richard L. Guerrant.   

Abstract

Glutamine is the major fuel for the gut as well as for many cells in the immune system that becomes conditionally essential during catabolic states. Glutamine supplementation improves intestinal mucosal repair and function. Glutamine, even at high doses, is without side effects and is well tolerated. Though unstable in solution, this is overcome by creating stable dipeptides such as alanyl-glutamine. In HIV-positive patients with wasting, glutamine enhances intestinal absorptive function and weight gain. Glutamine enhances sodium and water absorption in a rabbit model of cholera and Cryptosporidium-infected piglet intestine. Both glutamine and alanyl-glutamine have recently proven effective in a bovine model of Cryptosporidium as well. Finally, a rat model of cholera toxin-induced diarrhea also showed that alanyl-glutamine enhanced water and electrolyte intestinal absorption even better than the traditional glucose solutions. Clearly glutamine and its stabler derivatives hold promise for enhancing repair of mucosal injury by a wide range of infections or toxic agents, and hence have great potential as a new oral rehydration and nutrition therapy for patients with enteric infection, malnutrition, or chemotherapy- or radiation-induced enteritis.

Entities:  

Year:  2003        PMID: 12641996     DOI: 10.1007/s11908-003-0046-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  69 in total

1.  Development of L-glutamine-stimulated electroneutral sodium absorption in piglet jejunum.

Authors:  J M Rhoads; E O Keku; L E Bennett; J Quinn; J G Lecce
Journal:  Am J Physiol       Date:  1990-07

2.  Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial.

Authors:  J K Shabert; C Winslow; J M Lacey; D W Wilmore
Journal:  Nutrition       Date:  1999 Nov-Dec       Impact factor: 4.008

3.  Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia.

Authors:  P E Wischmeyer; M Kahana; R Wolfson; H Ren; M M Musch; E B Chang
Journal:  Shock       Date:  2001-11       Impact factor: 3.454

4.  Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer.

Authors:  C Decker-Baumann; K Buhl; S Frohmüller; A von Herbay; M Dueck; P M Schlag
Journal:  Eur J Cancer       Date:  1999-02       Impact factor: 9.162

5.  Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma.

Authors:  A P Houdijk; E R Rijnsburger; J Jansen; R I Wesdorp; J K Weiss; M A McCamish; T Teerlink; S G Meuwissen; H J Haarman; L G Thijs; P A van Leeuwen
Journal:  Lancet       Date:  1998-09-05       Impact factor: 79.321

6.  The prophylactic and therapeutic effects of glutamine- and arginine-enriched diets on radiation-induced enteritis in rats.

Authors:  S Ersin; P Tuncyurek; M Esassolak; M Alkanat; C Buke; M Yilmaz; A Telefoncu; T Kose
Journal:  J Surg Res       Date:  2000-04       Impact factor: 2.192

7.  Glutamine-supplemented total parenteral nutrition improves gut immune function.

Authors:  D J Burke; J C Alverdy; E Aoys; G S Moss
Journal:  Arch Surg       Date:  1989-12

8.  Effect of free glutamine and alanyl-glutamine dipeptide on mucosal proliferation of the human ileum and colon.

Authors:  W Scheppach; C Loges; P Bartram; S U Christl; F Richter; G Dusel; P Stehle; P Fuerst; H Kasper
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

9.  Cryptosporidial and microsporidial infections in human immunodeficiency virus-infected patients in northeastern Brazil.

Authors:  T Wuhib; T M Silva; R D Newman; L S Garcia; M L Pereira; C S Chaves; S P Wahlquist; R T Bryan; R L Guerrant; A de Q Sousa
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

10.  A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS.

Authors:  C M Noyer; D Simon; A Borczuk; L J Brandt; M J Lee; V Nehra
Journal:  Am J Gastroenterol       Date:  1998-06       Impact factor: 10.864

View more
  15 in total

1.  Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro.

Authors:  Benedito A Carneiro; Jun Fujii; Gerly A C Brito; Cirle Alcantara; Reinaldo B Oriá; Aldo A M Lima; Tom Obrig; Richard L Guerrant
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 3.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

4.  Phenylalanine isotope pulse method to measure effect of sepsis on protein breakdown and membrane transport in the pig.

Authors:  Gabriella A M Ten Have; Mariëlle P K J Engelen; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-03-14       Impact factor: 4.310

5.  Novel in vitro and in vivo models and potential new therapeutics to break the vicious cycle of Cryptosporidium infection and malnutrition.

Authors:  Lourrany B Costa; Francisco Jose Noronha; James K Roche; Jesus Emmanuel Sevilleja; Cirle A Warren; Reinaldo Oriá; Aldo Lima; Richard L Guerrant
Journal:  J Infect Dis       Date:  2012-03-26       Impact factor: 5.226

6.  Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.

Authors:  Raphael S Rodrigues; Renato A C Oliveira; Yuesheng Li; Snjezana Zaja-Milatovic; Lourrany B Costa; Manuel B Braga Neto; Glynis L Kolling; Aldo A Lima; Richard L Guerrant; Cirle Alcantara Warren
Journal:  J Infect Dis       Date:  2013-01-28       Impact factor: 5.226

Review 7.  Malnutrition as an enteric infectious disease with long-term effects on child development.

Authors:  Richard L Guerrant; Reinaldo B Oriá; Sean R Moore; Mônica O B Oriá; Aldo A M Lima
Journal:  Nutr Rev       Date:  2008-09       Impact factor: 7.110

8.  Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro.

Authors:  Manuel B Braga-Neto; Cirle A Warren; Reinaldo B Oriá; Manuel S Monteiro; Andressa A S Maciel; Gerly A C Brito; Aldo A M Lima; Richard L Guerrant
Journal:  Dig Dis Sci       Date:  2008-03-06       Impact factor: 3.199

9.  Improving the ORS: does glutamine have a role?

Authors:  Pradip K Bardhan
Journal:  J Health Popul Nutr       Date:  2007-09       Impact factor: 2.000

10.  Fecal Microbiota Functional Gene Effects Related to Single-Dose Antibiotic Treatment of Travelers' Diarrhea.

Authors:  Ryan C Johnson; Joy D Van Nostrand; Michele Tisdale; Brett Swierczewski; Mark P Simons; Patrick Connor; Jamie Fraser; Angela R Melton-Celsa; David R Tribble; Mark S Riddle
Journal:  Open Forum Infect Dis       Date:  2021-05-28       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.